Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes.

International journal of molecular sciences - 14 Jun 2024

Nkoy Flory L, Stone Bryan L, Deering-Rice Cassandra E, Zhu Angela, Lamb John G, Rower Joseph E, Reilly Christopher A

Abstract excerpt

Genetic variation among inhaled corticosteroid (ICS)-metabolizing enzymes may affect asthma control, but evidence is limited. This study tested the hypothesis that single-nucleotide polymorphisms (SNPs) in Cytochrome P450 3A5 (CYP3A5) would affect asthma outcomes. Patients aged 2-18 years with persistent asthma were recruited to use the electronic AsthmaTracker (e-AT), a self-monitoring tool that records weekly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Asthma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Cytochrome P-450 CYP3A

Share to Hydrocortisone

Share to Saliva

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 38928254
DOI: 10.3390/ijms25126548
PMCID: PMC11203737

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes.PMID 38928254Read ↗

Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium.Semantic proximity Read ↗

Fluticasone Propionate Pharmacogenetics: CYP3A4*22 Polymorphism and Pediatric Asthma ControlSemantic proximity Read ↗

Pharmacogenetics of asthma controller treatment.Semantic proximity Read ↗

Effect of CYP3A5 and CYP3A4 Genetic Variants on Fentanyl Pharmacokinetics in a Pediatric Population.Semantic proximity Read ↗

The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use.Semantic proximity Read ↗

Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonistsSemantic proximity Read ↗

The Cytochrome P450 2C8*3 Variant (rs11572080) Is Associated with Improved Asthma Symptom Control in Children and Altered Lipid Mediator Production and Inflammatory Response in Human Bronchial Epithelial Cells.Semantic proximity Read ↗

Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study.Semantic proximity Read ↗

Pharmacogenetics of CYP3A5 in Pediatric Patients With Eosinophilic Esophagitis.Semantic proximity Read ↗

ST13 polymorphisms and their effect on exacerbations in steroid-treated asthmatic children and young adults.Semantic proximity Read ↗

Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation.Semantic proximity Read ↗

The impact of glucocorticoid polymorphisms on markers of neonatal respiratory disease after antenatal betamethasone administration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.